siRNA, Anti-9230110C19Rik, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT101026WQ-2OMe)
The product SIRGT101026WQ-2OMe is a type of small interfering RNA (siRNA) that targets 9230110C19Rik gene and regulates the expression of gene. The siRNA interferes with the expression of 9230110C19Rik gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_199017.3 |
| Alternative Names | Cfap300 |
| Related Diseases | Primary Ciliary Dyskinesia 38 |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT102026WQ-2F | 9230110C19Rik | Mouse | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT103026WQ-2MOE | 9230110C19Rik | Mouse | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT104026WQ-LNA | 9230110C19Rik | Mouse | Locked Nucleic Acid (LNA) | ||
| SIRGT101026WQ-RB | 9230110C19Rik | Mouse | Ribo-modified | ||
| SIRGT102026WQ-BB | 9230110C19Rik | Mouse | Backbone-modified |
